Despite in patients from registry it was shown that the incidence of tuberculosis appears higher among users of anti-TNF than among users of other non-anti-TNF biologics (30), anti-TNF drugs can be employed with a satisfactory safety profile in patients with risk of LTBI (31). This evidence concerns the gene TNF and tuberculosis.